A respiratory vaccine platform shows promise against pertussis (whooping cough) by providing sterilizing immunity and generating local mucosal immunity. This approach could potentially solve the inability of current vaccines to prevent transmission.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Domenech de Celles, M. & Rohani, P. Nat. Rev. Microbiol. 22, 722–735 (2024).
Kuehn, B. M. JAMA 326, 300 (2021).
Jazayeri, S. D., Borkner, L., Sutton, C. E. & Mills, K. H. G. Nat. Microbiol. https://doi.org/10.1038/s41564-025-02166-6 (2025).
Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Proc. Natl Acad. Sci. USA 111, 787–792 (2014).
da Silva Antunes, R. et al. J. Clin. Invest. 128, 3853–3865 (2018).
Ross, P. J. et al. PLoS Pathog. 9, e1003264 (2013).
Wilk, M. M. et al. Emerg. Microbes Infect. 8, 169–185 (2019).
FDA approves nasal spray influenza vaccine for self- or caregiver administration. FDA (20 September 2024); http://go.nature.com/3KBVV5g
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
da Silva Antunes, R., Sette, A. New life into pertussis prevention. Nat Microbiol 10, 3045–3046 (2025). https://doi.org/10.1038/s41564-025-02169-3
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41564-025-02169-3